𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interaction of basic fibroblast growth factor with bovine growth plate chondrocytes

✍ Scribed by Dr. S. B. Trippel; M. C. Whelan; M. Klagsbrun; Dr. S. R. Doctrow


Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
853 KB
Volume
10
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The basic fibroblast growth factor (bFGF) family of peptides influences a wide range of cellular actions. To better understand the possible role of bFGF in the growth plate, we have characterized the interaction of this growth factor with isolated bovine growth plate chondrocytes. Basic FGF interacts with two classes of binding sites on these cells. One is consistent with high‐affinity bFGF receptors and the other with low‐affinity heparin‐like binding sites on the chondrocyte surface. Radiolabeled bFGF binding studies revealed approximately 4 × 10^6^ binding sites per cell, with a K~d~ of approximately 42 n__M__. Graded concentrations of heparin or NaCl competed with [^125^I]‐labeled bFGF in a dose‐dependent fashion, reducing [^125^I]‐labeled bFGF binding by 75 and 97%, respectively. The data suggest the presence of a high‐capacity, low‐affinity class of binding sites with the properties of a heparin‐like moiety. Affinity cross‐linking of [^125^I]‐labeled bFGF to chondrocytes labeled two principal species with apparent molecular masses of 135 and 160 kDa. Labeled bFGF was specifically displaced from both species by subnanomolar concentrations of unlabeled bFGF. These high‐affinity, low‐capacity binding sites are characteristic of classical bFGF receptors. Binding of [^125^I]‐labeled bFGF to these sites was also influenced by heparin, consistent with coregulation of binding to the two classes of binding sites. The data suggest that bFGF participates in the regulation of skeletal growth at the growth plate and that this regulation may involve bFGF interaction with at least two distinct classes of binding sites.


📜 SIMILAR VOLUMES


Modulation of the epidermal growth facto
✍ Pamela A. Maher 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

Institute for Diabetes and Endocrinology, La lolla, California 92(1.?7 Treatment of Swiss 3T3 fibroblasts with basic fibroblast growth factor (bFGF) lead to a rapid reduction in epidermal growth factor (EGF) binding and a slower inhibition of EGF receptor autophosphorylation. The reduction in bindi

Platelet-derived growth factor or basic
✍ Helen Palmer; Veronica M. Maher; J. Justin McCormick 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

Anchorage-independent growth, i.e., growth in semi-solid medium is considered a marker of cellular transformation of fibroblast cells. Diploid human fibroblasts ordinarily do not exhibit such growth but can grow transiently when medium contains high concentrations of fetal bovine serum. This suggest

Localization of basic fibroblast growth
✍ Anne Hanneken; Gerard A. Lutty; D. Scott McLeod; Frank Robey; Anita K. Harvey; L 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 648 KB

The basic fibroblast growth factor (FGF) is a potent mitogen that has vascular endothelium as one of its principle target cells. Recent work has provided both the complete amino acid sequence of basic FGF and the nucleotide sequence of the genes for both human and bovine basic FGF. Although capillar